Pitavastatin Calcium TCI P2071 is a chemical compound widely used in pharmaceutical research and biochemical studies. It plays a crucial role in laboratory settings where the inhibition of HMG-CoA reductase is the focus of investigation. This enzyme is a key target for statin drugs, making Pitavastatin Calcium an essential reagent for understanding lipid metabolism and cholesterol regulation. Its application extends to experimental studies aimed at evaluating pharmacological effects and the mechanisms of action of various compounds.
The compound is valued for its chemical stability and solubility in organic solvents such as ethanol and acetone. Its maximum water content of 15% ensures consistent quality and minimizes the risk of rapid degradation, making it ideal for high-precision research. This property is particularly important in experiments requiring reproducibility and accuracy. Additionally, its safe handling profile reduces potential hazards for researchers, ensuring a controlled and secure laboratory environment.
In Indonesian laboratories, Pitavastatin Calcium is commonly utilized in pharmacological research, especially in academic institutions and research centers. It is integral to drug development processes and studies on cholesterol therapy. Its reliability and performance make it a preferred choice for researchers aiming to advance therapeutic innovations and scientific understanding.
TCI brochures (PDF)
- HMG-CoA Reductase Inhibitors Statins(PP003E)202609 2026-09-10 · p. 1
- Pharmaceutical Ingredients for Research and Experimental Use 2026-03-09 · p. 22
Related TCI products
- TCI P1796 81131-70-6 Pravastatin Sodium
- TCI U0141 2055540-61-7 UltraCat (contains 5% Nitromethane at maximum)
- TCI T2581 2438-10-0 (+)-Terpinen-4-ol (contains 35% (-)-Terpinen-4-ol at maximum)
- TCI B0395 117-61-3 2,2'-Benzidinedisulfonic Acid (contains 20% Water at maximum)
- TCI R0180 147098-20-2 Rosuvastatin Calcium
- TCI R0136 1295649-40-9 Ru-MACHO(regR) (contains 5% Toluene at maximum)
- Pharmaceutical research for studying HMG-CoA reductase inhibition and lipid metabolism pathways.
- Development of new cholesterol-lowering drugs through experimental pharmacological evaluation.
- Biochemical studies focused on enzyme activity and metabolic regulation in cellular systems.
- Academic research in universities and research institutes exploring cardiovascular disease mechanisms.
- Clinical trial preparation for assessing the efficacy and safety of statin-based therapies.
| Brand | TCI |
|---|---|
| CAS number | 147526-32-7 |
| Molecular formula | — |
| Purity | — |
| Category | Life Science > Biochemicals and Reagents > Pharmaceutical Research Reagents |
| Pack sizes | 32 g |
| Physical form | Solid |
| Storage | Store in a cool, dry place away from moisture and direct sunlight. |
Pitavastatin Calcium should be stored in a cool, dry environment to maintain its chemical stability and prevent degradation. It is recommended to keep the product in a sealed container to minimize exposure to moisture and air. Due to its organic solubility, it is advisable to use glass or plastic containers that are resistant to chemical interaction. Laboratory personnel should handle the compound with appropriate personal protective equipment, such as gloves and safety goggles, to ensure safe handling. The material is non-hazardous under normal conditions but should be stored away from incompatible substances to maintain safety standards. Regular monitoring of storage conditions is essential to preserve the integrity of the compound for experimental use.
—
Product Categories
- Biochemicals and ReagentsPharmaceutical Research Reagents (for Experimental Use)Antilipemic Ingredients (for Research and Experimental Use)
- Biochemicals and Reagents
- Pharmaceutical Development and Drug Discovery ResearchPharmaceutical Research Reagents (for Experimental Use)Antilipemic Ingredients (for Research and Experimental Use)






